Dr. Mayank Choubey serves as an Associate Scientist at New York University Long Island School of Medicine in NY, USA. His research is centered on elucidating the novel molecular mechanisms of RXR alpha and Nogo B-Receptor (NgBR) proteins in diverse pathophysiological conditions related to the liver and metabolism. Specifically, his investigations span a range of hepatic and metabolic diseases, including but not limited to non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), liver fibrosis, liver cancer, and aging, and the interplay of these pathological conditions with type 2 diabetes mellitus (T2DM) and obesity. Dr. Choubey earned his Ph.D. from Banaras Hindu University in India and possesses valuable postdoctoral research experience in the metabolic physiology of the liver and adipose tissue. His primary research focus lies in comprehending the role of the RXR alpha protein and its correlation with various cardiovascular diseases associated with NAFLD.